Current Issue Jul-Aug 2026; Volume 6, Issue 4
ISSUE HIGHLIGHTS
Diagnostic and Prognostic Applications of PET/CT in Small-cell Lung Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
608-618
DOI: 10.21873/cdp.10561
CDKN2A mRNA Over-expression Is Associated With CD8+ T Cell Exclusion and IDO1-Mediated Adaptive Immune Resistance in Gastric Adenocarcinoma
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
639-648
DOI: 10.21873/cdp.10564
Living-donor Kidney Transplantation After Resection of Mixed Epithelial and Stromal Tumor: A Positive Outcome Despite Not Observing the Recommended Waiting Period
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
674-681
DOI: 10.21873/cdp.10567
Comparison of Automated Urinalysis Parameter Atyp.C and Urine Cytology for Detecting Bladder Carcinoma In Situ
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
715-722
DOI: 10.21873/cdp.10571
Purchase access
Email Alerts
Table of contents Jul-Aug 2026; Volume 6, Issue 4
Review articles
Diagnostic and Prognostic Applications of PET/CT in Small-cell Lung Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
608-618
DOI: 10.21873/cdp.10561
Impact of Local Treatment of the Primary Tumor on Overall Survival in De Novo Metastatic Breast Cancer: A Systematic Review and Meta-analysis
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
619-629
DOI: 10.21873/cdp.10562
Research articles
Lipid Profiles in Breast Cancer: Clinical Associations and Biological Insights
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
630-638
DOI: 10.21873/cdp.10563
CDKN2A mRNA Over-expression Is Associated With CD8+ T Cell Exclusion and IDO1-Mediated Adaptive Immune Resistance in Gastric Adenocarcinoma
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
639-648
DOI: 10.21873/cdp.10564
HER2 Expression and Nuclear Localization in Clear Cell Renal Cell Carcinoma: Implications for Prognosis and Therapeutic Targeting
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
649-659
DOI: 10.21873/cdp.10565
Optimized Prostate Cancer Stage Classification Using XGBoost Based on Racial miRNA Expression
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
660-673
DOI: 10.21873/cdp.10566
Living-donor Kidney Transplantation After Resection of Mixed Epithelial and Stromal Tumor: A Positive Outcome Despite Not Observing the Recommended Waiting Period
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
674-681
DOI: 10.21873/cdp.10567
Baseline Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival in PD-L1-positive Advanced Triple-negative Breast Cancer With Immune-checkpoint-inhibitor Treatment
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
682-691
DOI: 10.21873/cdp.10568
Prognostic Impact of Skeletal Muscle Radiodensity in Advanced Urothelial Carcinoma Undergoing Avelumab Maintenance Therapy
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
692-702
DOI: 10.21873/cdp.10569
Prognosis Using Modified Albumin–Bilirubin Grade in Resected Biliary Tract Cancer: A Multicenter Propensity Score–matched Analysis
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
703-714
DOI: 10.21873/cdp.10570
Comparison of Automated Urinalysis Parameter Atyp.C and Urine Cytology for Detecting Bladder Carcinoma In Situ
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
715-722
DOI: 10.21873/cdp.10571
Tumor Marker Index Based on CEA and CA19-9 as a Prognostic Biomarker in Resectable Colon Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
723-728
DOI: 10.21873/cdp.10572
The Clinical Impact of Prognostic Nutritional Index at Recurrence of Pancreatic Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
729-736
DOI: 10.21873/cdp.10573
The Impact of Comprehensive Panel NGS Testing and Cascade Family Screening on Early Diagnosis of Prostate Cancer and MINAS (ATM+MITF) Management
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
737-744
DOI: 10.21873/cdp.10574
Possible Sarcopenia and Functional Decline After Colorectal or Gastric Cancer Surgery
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
745-754
DOI: 10.21873/cdp.10575
Total Bone Uptake as a Quantitative Imaging Biomarker for Prostate Cancer With Bone Metastases
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
755-760
DOI: 10.21873/cdp.10576
Clinical Significance of Transjugular Liver Biopsy in Liver Dysfunction During Immune Checkpoint Inhibitor Therapy
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
761-768
DOI: 10.21873/cdp.10577
When Blood Speaks Before the Scan: The Role of ctDNA in Real-time CRC Care
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
769-779
DOI: 10.21873/cdp.10578
Early Initiation of Adjuvant Nivolumab After Esophagectomy Is Associated With Immune-related Liver Injury
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
780-794
DOI: 10.21873/cdp.10579
Cancer of Unknown Primary Most Suggestive of Colorectal Origin With Microsatellite Instability-high Status and High Tumor Mutation Burden Including NTRK Fusion
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
795-802
DOI: 10.21873/cdp.10580
From Ascites to Malignant Peritoneal Mesothelioma: The Diagnostic Workup of a Rare Tumor
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
803-809
DOI: 10.21873/cdp.10581
Pediatric Distal Femoral Surface Tumor With Extraosseous Lesion Mimicking Parosteal Osteosarcoma: A Diagnostic Challenge
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
810-819
DOI: 10.21873/cdp.10582
Orbital Metastasis of Pancreatic Cancer Not Detected on MRI at the Time of Clinical Presentation
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
820-824
DOI: 10.21873/cdp.10583